[1]
M. Seyyar, P. Can Şancı, and D. Çabuk, “Management of Trastuzumab Deruxtecan-Induced Heart Failure and Pneumonitis in a Patient with HER2-Positive Metastatic Breast Cancer: Trastuzumab Deruxtecan-Induced HF and Pneumonia”, Avicenna Anatol J Med, vol. 2, no. 1, pp. 21–24, Jun. 2025.